Emerging roles of JAK-STAT signaling pathways in adipocytes

Trends in Endocrinology and Metabolism

Volumn 22, Issue 8, 2011, Pages 325-332

  Richard, Allison J ^a   Stephens, Jacqueline M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; JANUS KINASE; STAT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; GENE TARGETING; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; HUMANS; JANUS KINASES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 79960913754     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.03.007     Document Type: Review

References (94)

1. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
2. Schindler C.W. Series introduction JAK-STAT signaling in human disease. J. Clin. Invest. 2002, 109:1133-1137.
3. Schindler C., Darnell J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 1995, 64:621-651.
4. Stewart W.C., et al. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: coordinate regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha. Biochim. Biophys. Acta 1999, 1452:188-196.
5. Hellgren G., et al. Growth hormone receptor interaction with Jak proteins differs between tissues. J. Interferon Cytokine Res. 2001, 21:75-83.
6. Balhoff J.P., Stephens J.M. Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 1998, 247:894-900.
7. Fleenor D., et al. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm. Res. 2006, 66:101-110.
8. Kawai M., et al. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J. Mol. Endocrinol. 2007, 38:19-34.
9. McGillicuddy F.C., et al. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 2009, 284:31936-31944.
10. Stephens J.M., et al. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J. Biol. Chem. 1998, 273:31408-31416.
11. Story D.J., Stephens J.M. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes. Obesity (Silver Spring) 2006, 14:1303-1311.
12. Zvonic S., et al. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo. Biochem. Biophys. Res. Commun. 2003, 302:359-362.
13. Zvonic S., et al. The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J. Biol. Chem. 2003, 278:2228-2235.
14. Zvonic S., et al. Effects of cardiotrophin on adipocytes. J. Biol. Chem. 2004, 279:47572-47579.
15. Ott V., et al. Direct effects of ciliary neurotrophic factor on brown adipocytes: evidence for a role in peripheral regulation of energy homeostasis. J. Endocrinol. 2002, 173:R1-R8.
16. Gregoire F., et al. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J. Cell. Physiol. 1992, 151:300-309.
17. Keay S., Grossberg S.E. Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc. Natl. Acad. Sci U.S.A. 1980, 77:4099-4103.
18. Miyaoka Y., et al. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J. Biol. Chem. 2006, 281:37913-37920.
19. Song H.Y., et al. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J. Cell. Biochem. 2007, 101:1238-1251.
20. White U.A., Stephens J.M. Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 2010, 318:10-14.
21. Thompson B.R., et al. Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling. J. Biol. Chem. 2009, 284:13473-13480.
22. Stephens J.M., et al. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 1996, 271:10441-10444.
23. Harp J.B., et al. Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochem. Biophys. Res. Commun. 2001, 281:907-912.
24. Meraz M.A., et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442.
25. Deng J., et al. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis. Endocrinology 2000, 141:2370-2376.
26. Wang D., et al. Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma). Biol. Cell 2010, 102:1-12.
27. Zhang K., et al. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPbeta transcription. J. Cell. Biochem. 2011, 112:488-497.
28. Deng J., et al. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochem. Biophys. Res. Commun. 2006, 339:923-931.
29. Cernkovich E.R., et al. Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells. Endocrinology 2007, 148:1598-1604.
30. Machinal-Quelin F., et al. Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways. Am. J. Physiol. Cell Physiol. 2002, 282:C853-C863.
31. Wu Z., et al. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta C/EBPdelta, and glucocorticoids. Mol. Cell. Biol. 1996, 16:4128-4136.
32. Stephens J.M., et al. PPARgamma ligand-dependent induction of STAT1 STAT5A, and STAT5B during adipogenesis. Biochem. Biophys. Res. Commun. 1999, 262:216-222.
33. Floyd Z.E., Stephens J.M. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes 2003, 52:308-314.
34. Baugh J.E., et al. The modulation of STAT5A/GR complexes during fat cell differentiation and in mature adipocytes. Obesity (Silver Spring) 2007, 15:583-590.
35. Yarwood S.J., et al. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J. Biol. Chem. 1999, 274:8662-8668.
36. Shang C.A., Waters M.J. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol. Endocrinol. 2003, 17:2494-2508.
37. Nanbu-Wakao R., et al. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol. Endocrinol. 2002, 16:1565-1576.
38. Stewart, W.C. et al. (2011) STAT5A expression in Swiss 3T3 cells promotes adipogenesis in vivo in an athymic mice model system. Obesity (Silver Spring).(in press), doi:10.1038/oby.2011.66.
39. Teglund S., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
40. Meirhaeghe A., et al. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler. Thromb. Vasc. Biol 2003, 23:289-294.
41. Fajas L., et al. PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett. 1998, 438:55-60.
42. Hogan J.C., Stephens J.M. The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter. Biochem. Biophys. Res. Commun. 2001, 287:484-492.
43. Waite K.J., et al. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J. Biol. Chem. 2001, 276:7062-7068.
44. Barroso I., et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999, 402:880-883.
45. Koivisto V.A., et al. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989, 38:641-647.
46. Shiba T., et al. Hyperglycaemia due to insulin resistance caused by interferon-gamma. Diabet. Med. 1998, 15:435-436.
47. Hogan J.C., Stephens J.M. STAT 1 binds to the LPL promoter in vitro. Biochem. Biophys. Res. Commun. 2003, 307:350-354.
48. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 1996, 37:693-707.
49. Doerrler W., et al. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994, 6:478-484.
50. Feingold K.R., et al. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 1992, 130:10-16.
51. Coulter A.A., Stephens J.M. STAT5 activators modulate acyl CoA oxidase (AOX) expression in adipocytes and STAT5A binds to the AOX promoter in vitro. Biochem. Biophys. Res. Commun. 2006, 344:1342-1345.
52. Nanbu-Wakao R., et al. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol. Endocrinol. 2000, 14:307-316.
53. Richter H.E., et al. The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation. J. Mol. Endocrinol. 2003, 30:139-150.
54. Hogan J.C., Stephens J.M. The regulation of fatty acid synthase by STAT5A. Diabetes 2005, 54:1968-1975.
55. White U.A., et al. The STAT5A-mediated induction of pyruvate dehydrogenase kinase 4 expression by prolactin or growth hormone in adipocytes. Diabetes 2007, 56:1623-1629.
56. Deng J., et al. Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes. Biochem. Biophys. Res. Commun. 2000, 267:516-520.
57. Ling C., et al. Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J. Clin. Endocrinol. Metab. 2003, 88:1804-1808.
58. Fortun-Lamothe L., et al. Influence of prolactin on in vivo and in vitro lipolysis in rabbits. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1996, 115:141-147.
59. Fielder P.J., Talamantes F. The lipolytic effects of mouse placental lactogen II, mouse prolactin, and mouse growth hormone on adipose tissue from virgin and pregnant mice. Endocrinology 1987, 121:493-497.
60. Flint D.J., et al. Prolactin and the regulation of adipose-tissue metabolism during lactation in rats. Mol. Cell. Endocrinol. 1981, 22:265-275.
61. Fain J.N., et al. Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice. Biochem. Biophys. Res. Commun. 1999, 263:201-205.
62. White U.A., et al. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo. Obesity (Silver Spring) 2011, 10.1038/oby.2010.293.
63. Zvonic S., et al. Cross-talk among gp130 cytokines in adipocytes. J. Biol. Chem. 2005, 280:33856-33863.
64. Bates S.H., et al. Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metab. 2005, 1:169-178.
65. Buettner C., et al. Critical role of STAT3 in leptin's metabolic actions. Cell Metab. 2006, 4:49-60.
66. Gong Y., et al. The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J. Biol. Chem. 2007, 282:31019-31027.
67. Piper M.L., et al. Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons. Mol. Endocrinol. 2008, 22:751-759.
68. Flower L., et al. Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes. Cytokine 2003, 21:32-37.
69. Fried S.K., et al. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 1998, 83:847-850.
70. Natal C., et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E52-E60.
71. Hugo E.R., et al. LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology 2006, 147:306-313.
72. Brandebourg T., et al. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes. Metab. 2007, 9:464-476.
73. Hugo E.R., et al. Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J. Clin. Endocrinol. Metab. 2008, 93:4006-4012.
74. McFarland-Mancini M., et al. Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochem. Biophys. Res. Commun. 2006, 344:9-16.
75. O'Rourke R.W., et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int. J. Obes. (Lond.) 2009, 33:978-990.
76. Duffaut C., et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol 2009, 29:1608-1614.
77. Rocha V.Z., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 2008, 103:467-476.
78. Strissel K.J., et al. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010, 18:1918-1925.
79. Yang H., et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 2010, 185:1836-1845.
80. Floyd Z.E., Stephens J.M. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 2002, 277:4062-4068.
81. Sos B.C., et al. Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. J. Clin. Invest. 2011, 10.1172/JCI42894.
82. Cui Y., et al. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 2007, 46:504-513.
83. Barclay J.L., et al. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology 2011, 152:181-192.
84. Inoue H., et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 2004, 10:168-174.
85. Kinoshita S., et al. Role of hepatic STAT3 in the regulation of lipid metabolism. Kobe J. Med. Sci. 2008, 54:E200-E208.
86. Cernkovich E.R., et al. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 2008, 149:1581-1590.
87. Sethi J.K., et al. Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors. FEBS Lett. 2000, 469:77-82.
88. Hogan J.C., Stephens J.M. Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. J. Endocrinol. 2005, 185:485-496.
89. Smit L.S., et al. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 1996, 10:519-533.
90. Tenney R., et al. Interleukin 11 signaling in 3T3-L1 adipocytes. J. Cell. Physiol. 2005, 202:160-166.
91. Rotter V., et al. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 2003, 278:45777-45784.
92. Andersson C.X., et al. Insulin antagonizes interleukin-6 signaling and is anti-inflammatory in 3T3-L1 adipocytes. J. Biol. Chem. 2007, 282:9430-9435.
93. White U.A., et al. Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes. J. Biol. Chem. 2008, 283:22505-22512.
94. White U.A., Stephens J.M. Neuropoietin activates STAT3 independent of LIFR activation in adipocytes. Biochem. Biophys. Res. Commun. 2010, 395:48-50.